Noom vs PlushCare
PlushCare costs $50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
PlushCare
Best for: coverage in all 50 states, which most sellers will not confirm
Visit PlushCare →If you are choosing between Noom and PlushCare, the first difference is cost: PlushCare is $50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Noom leads our six-part score, 6.7 to 6.4.
Noom vs PlushCare price
PlushCare is the cheaper way in: $149 a month against $199 a month at Noom. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at PlushCare ($149 a month vs $199 a month); tirzepatide is cheaper at Noom ($349 a month vs $399 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Noom prices brand-name pens and compounded injections, while PlushCare prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.
Where each one treats patients
Noom does not publish where it ships, and PlushCare lists 50 states.
Pricing
Noom
PlushCare
Range up to $299/mo
Range up to $599/mo
What each price covers
Noom's price also covers the clinician visit and coaching, which PlushCare does not claim.
Noom is silent on the medication itself, shipping and lab work.
PlushCare is silent on shipping and coaching.
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
PlushCare
Covered by the monthly price
Medication
Charged on top
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Charged on top
Coaching
Not stated
Where each one scores higher
Overall, Noom scores 6.7 and PlushCare 6.4 out of 10.
Noom is stronger on value (4.4 vs 3.0), user experience (8.0 vs 7.0) and support (4.0 vs 0.0).
PlushCare is stronger on trust & safety (7.5 vs 6.5) and accessibility (10.0 vs 5.0).
Effectiveness is within half a point.
Noom
6.7/10
PlushCare
6.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Noom nor PlushCare has an FDA warning letter on record with us.
Features & Coverage
| Feature | Noom | PlushCare |
|---|---|---|
| Starting Price | $199/mo | ✓$149/mo |
| Features | 2 features | ✓8 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →About PlushCare
PlushCare is an established virtual primary-care telehealth platform and a subsidiary of Transcarent, Inc., a Delaware corporation that also owns Accolade, 2nd.MD, and 98point6 by Transcarent. Virtual visits with US board-certified physicians cost $30 per appointment insured and $129 self-pay. GLP-1 prescribing is a clinician-discretionary option within the broader primary-care relationship.
Read our full PlushCare review →Pros & Cons
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
PlushCare
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves all 50 states
- We found no FDA warning letters issued to PlushCare
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- Baseline bloodwork is required before a prescription
Watch-outs
- Not included in the monthly price: medication, clinician visits, lab work
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Noom wins this one, 6.7 to 6.4, above all for coaching bundled into the price rather than sold separately. PlushCare undercuts it by $50 a month, so if the monthly bill is what decides it, PlushCare is the pick. PlushCare fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Choose PlushCare if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Noom vs PlushCare: FAQ
Close alternatives to Noom and PlushCare
- Noom vs Hims
- Noom vs Hers
- Noom vs Care Bare Rx
- Noom vs Concierge MD LA
- PlushCare vs altRX
- PlushCare vs Trinity Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.